These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 31831255)

  • 21. [Focus on Sjögren's syndrome - Diagnosis and treatment].
    Zehrfeld N; Witte T; Ernst D
    Dtsch Med Wochenschr; 2024 Jun; 149(12):734-739. PubMed ID: 38781999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sjögren's syndrome: where do we stand, and where shall we go?
    Cornec D; Jamin C; Pers JO
    J Autoimmun; 2014 Jun; 51():109-14. PubMed ID: 24612946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome.
    Brito-Zerón P; Retamozo S; Kostov B; Baldini C; Bootsma H; De Vita S; Dörner T; Gottenberg JE; Kruize AA; Mandl T; Ng WF; Seror R; Tzioufas AG; Vitali C; Bowman S; Mariette X; Ramos-Casals M
    RMD Open; 2019; 5(2):e001064. PubMed ID: 31749986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
    Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
    Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.
    De Vita S; Quartuccio L; Salvin S; Picco L; Scott CA; Rupolo M; Fabris M
    Clin Exp Rheumatol; 2014; 32(4):490-4. PubMed ID: 24802131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.
    Cortés J; Hidalgo J; Aguilera S; Castro I; Brito M; Urra H; Pérez P; Barrera MJ; Carvajal P; Urzúa U; González S; Molina C; Bahamondes V; Hermoso M; González MJ
    J Autoimmun; 2019 Feb; 97():88-99. PubMed ID: 30391023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
    Fox PC
    Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
    Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
    J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.
    Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A
    J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sjögren's syndrome].
    Umehara H; Sawaki T; Kawanami T; Masaki Y; Fukushima T
    Nihon Rinsho; 2009 Mar; 67(3):511-6. PubMed ID: 19280925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial.
    St Clair EW; Baer AN; Wei C; Noaiseh G; Parke A; Coca A; Utset TO; Genovese MC; Wallace DJ; McNamara J; Boyle K; Keyes-Elstein L; Browning JL; Franchimont N; Smith K; Guthridge JM; Sanz I; James JA;
    Arthritis Rheumatol; 2018 Sep; 70(9):1470-1480. PubMed ID: 29604186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sjögren's syndrome].
    Sugai S
    Nihon Rinsho; 2005 May; 63 Suppl 5():305-10. PubMed ID: 15954367
    [No Abstract]   [Full Text] [Related]  

  • 34. Evolving concepts of diagnosis, pathogenesis, and therapy of Sjögren's syndrome.
    Fox RI; Törnwall J; Maruyama T; Stern M
    Curr Opin Rheumatol; 1998 Sep; 10(5):446-56. PubMed ID: 9746861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic treatments in Sjögren's syndrome.
    Bowman S; Barone F
    Presse Med; 2012 Sep; 41(9 Pt 2):e495-509. PubMed ID: 22836195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.
    Reale M; D'Angelo C; Costantini E; Laus M; Moretti A; Croce A
    J Immunol Res; 2018; 2018():7510174. PubMed ID: 29977932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Sjögren's syndrome and deficiency of ICA69.
    Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
    Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sjögren's syndrome, the old and the new.
    Peri Y; Agmon-Levin N; Theodor E; Shoenfeld Y
    Best Pract Res Clin Rheumatol; 2012 Feb; 26(1):105-17. PubMed ID: 22424197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
    Dörner T; Posch MG; Li Y; Petricoul O; Cabanski M; Milojevic JM; Kamphausen E; Valentin MA; Simonett C; Mooney L; Hüser A; Gram H; Wagner FD; Oliver SJ
    Ann Rheum Dis; 2019 May; 78(5):641-647. PubMed ID: 30826774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.